vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Shimmick Corp (SHIM). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $141.9M, roughly 1.9× Shimmick Corp). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -3.1%, a 4.5% gap on every dollar of revenue. Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -10.1%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Shimmick Corp is a U.S.-based heavy civil construction firm specializing in building and upgrading critical public infrastructure, including water facilities, transportation systems, dams, and environmental remediation projects. It primarily serves federal, state, and local government clients across North America, delivering complex large-scale construction solutions for public sector segments.

ACAD vs SHIM — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.9× larger
ACAD
$268.1M
$141.9M
SHIM
Higher net margin
ACAD
ACAD
4.5% more per $
ACAD
1.4%
-3.1%
SHIM
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
5.3%
-10.1%
SHIM

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ACAD
ACAD
SHIM
SHIM
Revenue
$268.1M
$141.9M
Net Profit
$3.6M
$-4.4M
Gross Margin
7.6%
Operating Margin
-1.7%
-2.2%
Net Margin
1.4%
-3.1%
Revenue YoY
9.7%
Net Profit YoY
EPS (diluted)
$0.02
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
SHIM
SHIM
Q1 26
$268.1M
Q4 25
$284.0M
$141.9M
Q3 25
$278.6M
$128.4M
Q2 25
$264.6M
$122.1M
Q1 25
$244.3M
$103.6M
Q4 24
$259.6M
Q3 24
$250.4M
$166.0M
Q2 24
$242.0M
$90.6M
Net Profit
ACAD
ACAD
SHIM
SHIM
Q1 26
$3.6M
Q4 25
$273.6M
$-4.4M
Q3 25
$71.8M
$-8.5M
Q2 25
$26.7M
$-9.8M
Q1 25
$19.0M
$-38.5M
Q4 24
$143.7M
Q3 24
$32.8M
$-1.6M
Q2 24
$33.4M
$-51.4M
Gross Margin
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
90.8%
7.6%
Q3 25
92.2%
6.3%
Q2 25
92.2%
3.8%
Q1 25
91.7%
-20.1%
Q4 24
91.6%
Q3 24
92.5%
7.3%
Q2 24
92.5%
-34.4%
Operating Margin
ACAD
ACAD
SHIM
SHIM
Q1 26
-1.7%
Q4 25
6.1%
-2.2%
Q3 25
12.8%
-5.5%
Q2 25
12.2%
-7.3%
Q1 25
7.9%
-39.3%
Q4 24
59.1%
Q3 24
12.6%
0.7%
Q2 24
12.6%
-53.0%
Net Margin
ACAD
ACAD
SHIM
SHIM
Q1 26
1.4%
Q4 25
96.3%
-3.1%
Q3 25
25.8%
-6.6%
Q2 25
10.1%
-8.0%
Q1 25
7.8%
-37.1%
Q4 24
55.4%
Q3 24
13.1%
-0.9%
Q2 24
13.8%
-56.7%
EPS (diluted)
ACAD
ACAD
SHIM
SHIM
Q1 26
$0.02
Q4 25
$1.61
$-0.12
Q3 25
$0.42
$-0.25
Q2 25
$0.16
$-0.28
Q1 25
$0.11
$-0.92
Q4 24
$0.86
Q3 24
$0.20
$-0.05
Q2 24
$0.20
$-1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
SHIM
SHIM
Cash + ST InvestmentsLiquidity on hand
$17.6M
Total DebtLower is stronger
$57.5M
Stockholders' EquityBook value
$-52.7M
Total Assets
$1.6B
$218.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
$177.7M
$17.6M
Q3 25
$258.0M
$21.4M
Q2 25
$253.6M
$16.3M
Q1 25
$217.7M
$33.7M
Q4 24
$319.6M
Q3 24
$155.1M
$26.0M
Q2 24
$177.1M
$22.4M
Total Debt
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
$57.5M
Q3 25
$36.4M
Q2 25
$31.4M
Q1 25
$9.5M
Q4 24
Q3 24
$39.9M
Q2 24
Stockholders' Equity
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
$1.2B
$-52.7M
Q3 25
$917.3M
$-49.5M
Q2 25
$822.4M
$-42.6M
Q1 25
$765.2M
$-34.7M
Q4 24
$732.8M
Q3 24
$577.2M
$973.0K
Q2 24
$516.7M
$436.0K
Total Assets
ACAD
ACAD
SHIM
SHIM
Q1 26
$1.6B
Q4 25
$1.6B
$218.5M
Q3 25
$1.3B
$203.0M
Q2 25
$1.2B
$227.7M
Q1 25
$1.1B
$233.9M
Q4 24
$1.2B
Q3 24
$976.9M
$346.7M
Q2 24
$914.1M
$344.5M
Debt / Equity
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
41.01×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
SHIM
SHIM
Operating Cash FlowLast quarter
$-23.7M
Free Cash FlowOCF − Capex
$-28.7M
FCF MarginFCF / Revenue
-20.2%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
$-48.7M
$-23.7M
Q3 25
$74.3M
$-3.8M
Q2 25
$64.0M
$-38.2M
Q1 25
$20.3M
$44.9M
Q4 24
$40.4M
Q3 24
$63.2M
$12.7M
Q2 24
$25.0M
$-43.9M
Free Cash Flow
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
$-28.7M
Q3 25
$73.9M
$-4.2M
Q2 25
$-38.7M
Q1 25
$44.4M
Q4 24
Q3 24
$63.2M
$10.3M
Q2 24
$-46.8M
FCF Margin
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
-20.2%
Q3 25
26.5%
-3.2%
Q2 25
-31.7%
Q1 25
42.9%
Q4 24
Q3 24
25.2%
6.2%
Q2 24
-51.7%
Capex Intensity
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
3.5%
Q3 25
0.1%
0.3%
Q2 25
0.4%
Q1 25
0.5%
Q4 24
Q3 24
0.0%
1.4%
Q2 24
3.3%
Cash Conversion
ACAD
ACAD
SHIM
SHIM
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Segment breakdown not available.

SHIM
SHIM

Shimmick Projects$106.8M75%
Non Core Projects$35.1M25%

Related Comparisons